HC Wainwright & Co. Maintains Buy on Evotec, Lowers Price Target to $4

Benzinga Newsdesk www.benzinga.com Negative 63.9%

Neg 63.9% Neu 0% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Evotec (NASDAQ:EVO) with a Buy and lowers the price target from $7 to $4.